Yes-associated protein up-regulates jagged-1 and activates the NOTCH pathway in human hepatocellular carcinoma

Gastroenterology

Volumn 144, Issue 7, 2013, Pages

  Tschaharganeh, Darjus Felix ^a   Chen, Xin ^b   Latzko, Philipp ^a   Malz, Mona ^a   Gaida, Matthias Martin ^a   Felix, Klaus ^a   Ladu, Sara ^c   Singer, Stephan ^a   Pinna, Federico ^a   Gretz, Norbert ^d   Sticht, Carsten ^d   Tomasi, Maria Lauda ^e   Delogu, Salvatore ^f   Evert, Matthias ^f   Fan, Biao ^b   Ribback, Silvia ^f   Jiang, Lijie ^b   Brozzetti, Stefania ^g   Bergmann, Frank ^a   Dombrowski, Frank ^f   Schirmacher, Peter ^a   Calvisi, Diego Francesco ^f   Breuhahn, Kai ^a   more..

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CHIETI   (Italy)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f UNIVERSITY OF GREIFSWALD   (Germany)

^g SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Colorectal Cancer; Liver Cancer; Pancreatic Cancer; Transcriptional Regulators

Indexed keywords

ALANINE; BETA CATENIN; DOXYCYCLINE; JAGGED1; MST1 PROTEIN; MST2 PROTEIN; NOTCH RECEPTOR; PROTEIN KINASE YES; REGULATOR PROTEIN; RNA; SERINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TEAD4; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CARCINOMA CELL; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PATIENT SELECTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSGENIC ANIMAL; TUMOR CELL LINE; TUMOR XENOGRAFT;

EID: 84878273791     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2013.02.009     Document Type: Article

References (46)

1. Q. Zeng, W. Hong The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals Cancer Cell 13 2008 188 192
2. B. Zhao, K. Tumaneng, K.L. Guan The Hippo pathway in organ size control, tissue regeneration and stem cell self-renewal Nat Cell Biol 13 2011 877 883
3. B. Zhao, X. Wei, W. Li Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control Genes Dev 21 2007 2747 2761
4. A.A. Steinhardt, M.F. Gayyed, A.P. Klein Expression of Yes-associated protein in common solid tumors Hum Pathol 39 2008 1582 1589
5. J. Dong, G. Feldmann, J. Huang Elucidation of a universal size-control mechanism in Drosophila and mammals Cell 130 2007 1120 1133
6. M.Z. Xu, T.J. Yao, N.P. Lee Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma Cancer 115 2009 4576 4585
7. L. Zender, M.S. Spector, W. Xue Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach Cell 125 2006 1253 1267
8. F.D. Camargo, S. Gokhale, J.B. Johnnidis YAP1 increases organ size and expands undifferentiated progenitor cells Curr Biol 17 2007 2054 2060
9. K.P. Lee, J.H. Lee, T.S. Kim The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis Proc Natl Acad Sci U S A 107 2010 8248 8253
10. L. Lu, Y. Li, S.M. Kim Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver Proc Natl Acad Sci U S A 107 2010 1437 1442
11. D. Zhou, C. Conrad, F. Xia Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene Cancer Cell 16 2009 425 438
12. M. Cordenonsi, F. Zanconato, L. Azzolin The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells Cell 147 2011 759 772
13. M.C. Cantarini, S.M. de la Monte, M. Pang Aspartyl-asparagyl beta hydroxylase over-expression in human hepatoma is linked to activation of insulin-like growth factor and notch signaling mechanisms Hepatology 44 2006 446 457
14. R. Qi, H. An, Y. Yu Notch1 signaling inhibits growth of human hepatocellular carcinoma through induction of cell cycle arrest and apoptosis Cancer Res 63 2003 8323 8329
15. C. Wang, R. Qi, N. Li Notch1 signaling sensitizes tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human hepatocellular carcinoma cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression J Biol Chem 284 2009 16183 16190
16. X.Q. Wang, W. Zhang, E.L. Lui Notch1-Snail1-E-cadherin pathway in metastatic hepatocellular carcinoma Int J Cancer 131 2012 E163 E172
17. E. Bertini, T. Oka, M. Sudol YAP: at the crossroad between transformation and tumor suppression Cell Cycle 8 2009 49 57
18. B. Zhao, X. Ye, J. Yu TEAD mediates YAP-dependent gene induction and growth control Genes Dev 22 2008 1962 1971
19. Y. Liu-Chittenden, B. Huang, J.S. Shim Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP Genes Dev 26 2012 1300 1305
20. B. Zhao, J. Kim, X. Ye Both TEAD-binding and WW domains are required for the growth stimulation and oncogenic transformation activity of yes-associated protein Cancer Res 69 2009 1089 1098
21. D. Zhou, Y. Zhang, H. Wu Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance Proc Natl Acad Sci U S A 108 2011 E1312 E1320
22. V. Rodilla, A. Villanueva, A. Obrador-Hevia Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer Proc Natl Acad Sci U S A 106 2009 6315 6320
23. J. Zhang, J.Y. Ji, M. Yu YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway Nat Cell Biol 11 2009 1444 1450
24. E. Cho, Y. Feng, C. Rauskolb Delineation of a Fat tumor suppressor pathway Nat Genet 38 2006 1142 1150
25. X. Varelas, P. Samavarchi-Tehrani, M. Narimatsu The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway Dev Cell 19 2010 831 844
26. C. Yi, J.L. Kissil Merlin in organ size control and tumorigenesis: hippo versus EGFR? Genes Dev 24 2010 1673 1679
27. L.A. Fernandez, P.A. Northcott, J. Dalton YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation Genes Dev 23 2009 2729 2741
28. R. Urtasun, M.U. Latasa, M.I. Demartis Connective tissue growth factor autocriny in human hepatocellular carcinoma: oncogenic role and regulation by epidermal growth factor receptor/yes-associated protein-mediated activation Hepatology 54 2011 2149 2158
29. P. Viatour, U. Ehmer, L.A. Saddic Notch signaling inhibits hepatocellular carcinoma following inactivation of the RB pathway J Exp Med 208 2011 1963 1976
30. M. Liu, D.F. Lee, C.T. Chen IKKalpha activation of NOTCH links tumorigenesis via FOXA2 suppression Mol Cell 45 2012 171 184
31. B. Fan, Y. Malato, D.F. Calvisi Cholangiocarcinomas can originate from hepatocytes in mice J Clin Invest 122 2012 2911 2915
32. A. Villanueva, C. Alsinet, K. Yanger Notch signaling is activated in human hepatocellular carcinoma and induces tumor formation in mice Gastroenterology 143 2012 1660 1669
33. P. Ranganathan, K.L. Weaver, A.J. Capobianco Notch signalling in solid tumours: a little bit of everything but not all the time Nat Rev Cancer 11 2011 338 351
34. L. Boulter, O. Govaere, T.G. Bird Macrophage-derived Wnt opposes Notch signaling to specify hepatic progenitor cell fate in chronic liver disease Nat Med 18 2012 572 579
35. M.T. Dill, L. Tornillo, T. Fritzius Constitutive Notch2 signaling induces hepatic tumors in mice Hepatology 57 2012 1607 1619
36. L. Chen, S.W. Chan, X. Zhang Structural basis of YAP recognition by TEAD4 in the hippo pathway Genes Dev 24 2010 290 300
37. T. Nussbaum, J. Samarin, V. Ehemann Autocrine insulin-like growth factor-II stimulation of tumor cell migration is a progression step in human hepatocarcinogenesis Hepatology 48 2008 146 156
38. D.F. Tschaharganeh, M. Kaldenbach, S. Erschfeld Glycoprotein 130-dependent pathways in host hepatocytes are important for liver repopulation in mice Liver Transpl 16 2010 23 32
39. R.E. Moellering, M. Cornejo, T.N. Davis Direct inhibition of the NOTCH transcription factor complex Nature 462 2009 182 188
40. F.D. Camargo, S. Gokhale, J.B. Johnnidis YAP1 increases organ size and expands undifferentiated progenitor cells Curr Biol 17 2007 2054 2060
41. J.S. Lee, I.S. Chu, J. Heo Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling Hepatology 40 2004 667 676
42. D.F. Calvisi, C. Wang, C. Ho Increased lipogenesis, induced by AKT-mTORC1-RPS6 signaling, promotes development of human hepatocellular carcinoma Gastroenterology 140 2011 1071 1083
43. M. Malz, A. Weber, S. Singer Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells Hepatology 50 2009 1130 1139
44. M.N. Wente, M.M. Gaida, C. Mayer Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma Int J Oncol 33 2008 297 308
45. S. Singer, V. Ehemann, A. Brauckhoff Protumorigenic overexpression of stathmin/Op18 by gain-of-function mutation in p53 in human hepatocarcinogenesis Hepatology 46 2007 759 768
46. J. Schug Using TESS to predict transcription factor binding sites in DNA sequence Curr Protoc Bioinformatics 2008 Chapter 2:Unit 2